Alveolar Bone Regeneration- The Clinician’s Perspective!

Abstract

Periodontal disease is a chronic inflammatory disease affecting the supporting structures of the periodontium. This disease has a high global prevalence eventually affecting the quality of life of the individual due to tooth loss. The etiopathogenesis and pathology of periodontal disease is an ever-evolving research area in the field of periodontology. Newer treatment modalities have emerged that can be given to patients in addition to non-surgical and surgical periodontal therapy, which will remain the cornerstone of treatment for periodontal disease. The host immune inflammatory response contributes to the loss of periodontal support. Hence, alternative treatment modes targeting the host response can improve the outcome of periodontal treatment. Teriparatide is one such anabolic drug which is a recombinant form of parathyroid hormone. It has been used widely for treating osteoporosis but also has promising results in dentistry. This review focuses on the update of teriparatide and its periodontal applications for bone regeneration.